IRIS
BLONDEAUX, EVA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.589
Totale 1.589
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.589
Totale 1.589
Salva come PNG Salva come JPEG
Città #
Genova 1.060
Rapallo 291
Genoa 219
Bordighera 19
Totale 1.589
Salva come PNG Salva come JPEG
Nome #
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 128
Management of young women with early breast cancer 113
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 110
News on the medical treatment of young women with early-stage HER2-negative breast cancer 106
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients 104
Treatment with aromatase inhibitors and markers of cardiovascular disease 100
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer 89
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 88
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 86
Role of dose-dense chemotherapy in high-risk early breast cancer 85
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 84
PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy 67
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 66
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer 61
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 58
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 54
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 50
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study 44
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 35
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 32
null 27
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 19
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result 16
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition 15
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 9
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study 9
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies 8
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group 7
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis 6
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis 2
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials 1
Totale 1.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.600
article - articoli 6.600
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 0 0 0 0 0 0 0 29 29
2019/2020502 12 10 15 34 49 73 68 55 59 70 42 15
2020/2021263 20 17 42 27 13 28 10 25 23 27 16 15
2021/2022260 5 10 5 40 16 26 18 49 25 26 9 31
2022/2023344 28 33 3 38 66 51 9 22 45 4 41 4
2023/2024201 6 21 4 41 17 31 22 16 9 28 6 0
Totale 1.679